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Study Objectives: Tolerance to shift work varies; only some shift workers suffer from disturbed sleep, fatigue, and job-related exhaustion. Our aim was to 
explore molecular genetic risk factors for intolerance to shift work.
Methods: We assessed intolerance to shift work with job-related exhaustion symptoms in shift workers using the emotional exhaustion subscale of  the Maslach 
Burnout Inventory-General Survey, and carried out a genome-wide association study (GWAS) using Illumina’s Human610-Quad BeadChip (n = 176). The most 
significant findings were further studied in three groups of  Finnish shift workers (n = 577). We assessed methylation in blood cells with the Illumina HumanMeth-
ylation450K BeadChip, and examined gene expression levels in the publicly available eGWAS Mayo data.
Results: The second strongest signal identified in the GWAS (p = 2.3 × 10E-6) was replicated in two of  the replication studies with p < .05 (p = 2.0 × 10E-4 
when combining the replication studies) and indicated an association of  job-related exhaustion in shift workers with rs12506228, located downstream of  the 
melatonin receptor 1A gene (MTNR1A). The risk allele was also associated with reduced in silico gene expression levels of  MTNR1A in brain tissue and sugges-
tively associated with changes in DNA methylation in the 5' regulatory region of  MTNR1A.
Conclusions: These findings suggest that a variant near MTNR1A may be associated with job-related exhaustion in shift workers. The risk variant may exert 
its effect via epigenetic mechanisms, potentially leading to reduced melatonin signaling in the brain. These results could indicate a link between melatonin signa-
ling, a key circadian regulatory mechanism, and tolerance to shift work.
Keywords:  genome-wide association study, job-related exhaustion, shift work, MTNR1A, DNA methylation.
INTRODUCTION
In the Western world, about one in five employees is engaged in 
shift work.1 Performing shift work long-term has been linked 
to a number of adverse health effects, such as an increased 
risk of type 2 diabetes,2 coronary heart disease,3 and breast 
cancer.4 In daily life, the most common health-related effects 
of shift work are disturbed sleep–wake cycle and the associ-
ated sleep loss, which promote fatigue, and at worst can lead 
to shift work sleep disorder.5 Shift workers are also at higher 
risk for work-related stress syndrome burnout.6,7 Clearly, indi-
vidual differences do exist regarding tolerance to shift work 
since not all shift workers suffer from fatigue or other adverse 
consequences.8
The definition of intolerance to shift work and methods to 
assess it vary.9 The traditional definition offered by Andlauer 
et al.,10 and a later definition by Reinberg et al,11 both include 
persistent fatigue as one of the key symptoms, along with diges-
tive troubles, persistent sleep alterations,10,11 regular use of sleep 
medication, and changes in behavior.11 Persistent fatigue, which 
is long-lasting and not recovered by days-off,12 closely resem-
bles emotional exhaustion (job-related exhaustion), the core 
symptom of burnout also linked to ineffective rest,13 which can 
be measured by structured tools such as the Maslach Burnout 
Inventory-General Survey (MBI-GS).
Individual risk factors for intolerance to shift work include 
female gender, neuroticism and its related personality traits, 
and the morningness chronotype, especially with night work.9,14 
Genetic variants may also affect tolerance to shift work.8,9 
Interactions between circadian genes and a person’s sleep 
strategy (the timing and amount of sleep when switching from 
one shift to another) have been detected in adaptation to work 
schedules,15 and the frequencies of serotonin transporter gene 
variants and cryptochrome circadian clock 1 gene (CRY1) var-
iants vary between day workers and rotating night workers, 
potentially reflecting genotype-based selection.16,17 In a study of 
tolerance to sleep deprivation, a common consequence of shift 
Statement of Significance
This study represents the first systematic search for molecular genetic risk factors for intolerance to shift work, assessed with job-related exhaustion symp-
toms in shift workers. The study suggests a potential genetic risk variant for intolerance to shift work located near melatonin receptor 1A gene (MTNR1A). 
This variant is linked to lower expression levels of  MTNR1A and suggestively to changes in DNA methylation in the regulatory region of  MTNR1A. We 
propose that the reduced melatonin signaling through decreased MTNR1A expression may increase the rhythm-changing effects of  nocturnal light in shift 
workers and worsen circadian disruption. Given the wide use of  melatonergic drugs, defining the role that MTNR1A plays in tolerance to shift work warrants 
further investigation.
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work, the major part of the inter-individual variability in neu-
robehavioral deficits during sleep deprivation was due to trait-
like differential vulnerability,18 such that could be explained by 
genetic factors, for example. To our knowledge, no systematic 
molecular genetic search on the risk factors for intolerance to 
shift work has been carried out previously.
To identify molecular genetic risk factors for intolerance 
to shift work, we performed a genome-wide association 
study (GWAS) of job-related exhaustion, as measured by the 
MBI-GS, in shift workers of the Finnish general population and 
sought to replicate the strongest findings in subjects from the 
general population and subjects from two independent Finnish 
occupational groups, airline workers and nurses engaged in 
shift work. To investigate if an interaction of genetic risk factors 
and the shift work environment is mediated through molecular 
mechanisms affecting gene expression, we also studied in silico 




Carried out from 2000 to 2001 by the National Public Health 
Institute of Finland, the Health 2000 survey is an epidemio-
logical cohort representative of the Finnish population over 
the age of 30 (n = 8028).19 Subjects in our studies comprised 
individuals under 65 years old who perform three-shift work, 
two-shift work, or regular night work (Table 1). These subjects 
were defined based on the following questions asked of those 
indicating that they had been working in the last 12 months: 
“What sort of hours do/did you work in your main occupation: 
regular day-job (between 6 am and 6 pm), regular evening job, 
regular night job, two-shift work, three-shift work, periodical 
work, only weekend work, other sort of working time?” We 
included those reporting two-shift work, three-shift work, or 
regular night work. In Finland, three-shift work usually refers 
to 8-hour shift work schedules with morning/day, evening, and 
night shifts; while, two-shift work refers to shift work with only 
two different shifts which are normally the morning/day and the 
evening shift.
Comprised of equal numbers of cases and controls for meta-
bolic syndrome, the GenMets subcohort from the Health 2000 
survey was selected for genome-wide genotyping (n = 2130).20 
Our initial GWAS analyses comprised GenMets shift workers 
(Health 2000 GWAS study, n = 176 with successful genotyping 
and answered to MBI-GS) and the analyses were adjusted for 
the case-control status of GenMets (73 cases and 103 controls). 
A description of the selection of cases and controls is provided 
in the Supplementary Methods and basic characteristics of the 
cases and controls are provided in Supplementary Table S1. The 
two variants with the strongest association in GWAS were gen-
otyped in the rest of the Health 2000 cohort, which was not part 
of GenMets, and those shift workers were used in our first rep-
lication analysis (Health 2000 replication study, n = 241 with 
successful genotyping and answered to MBI-GS) (Table 1). The 
interaction analysis of the shift-work status included the shift 
working subjects in both the Health 2000 GWAS and Health 
2000 replication studies and, in addition, non-shift-working 
subjects of the Health 2000 (n = 2484 with successful genotyp-
ing and answered to MBI-GS).
The genetic fine mapping investigation was supplemented 
with two additional Finnish population cohorts, Vantaa 85+ 
(n = 532)21 and Kuopio 75+ (n = 601),22 which contained no 
information on shift work or job-related exhaustion. For a total 
of 14 subjects from Health 2000 and Vantaa 85+, we performed 
capillary sequencing, and thereafter Vantaa 85+ Kuopio 75+ 
Table 1—Study Characteristics.
Study Health 2000  
GWAS studya




In-flight workers  
of the airline studyd
Non-flight workers  
of the airline studyd
Occupation All All Nurses Pilots and flight attendants Workers at airport, eg,  
in catering or in cargo
Shift work type Three-shift, two-shift  
or regular night work
Three-shift, two-shift  
or regular night work
Three-shift 
work
night shifts ≥3/mo or/and  
early morning shifts ≥1/wk
night shifts ≥3/mo or/and 
early morning shifts ≥1/wk
Number of   
shift workers
176 241 73 263 343
MBI-GS exhaustion,  
mean (SD)
1.17 (1.23) 1.10 (1.18) 1.25 (1.08) 1.77 (0.87) 2.26 (1.22)
Age mean  
(SD, range)
46.7 (7.6, 30–61) 42.7, (8.4, 30–60) 47.7 (6.8, 31–59) 44.3 (8.2, 24–64) 43.8 (8.4, 24–60)
Males (%) 42.0 38.6 0 21.7 65.3
GWAS = genome-wide association study; MBI-GS = Maslach Burnout Inventory-General Survey.
aGenmets subcohort of  the Health 2000 Survey designed originally for case-control study of  metabolic syndrome.
bRespondents of  the Health 2000 survey who participate in the genetic study and were not part of  Genmets.
cSubset of  nurses from the Finnish Public Sector Study.25
dEmployees of  the airline company in the follow-up phase of  the study for diabetes screening and prevention implementation program in the occupational 
health care of  the Finnish airline.24
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were used in the fragment analysis of the microsatellite marker 
found by sequencing (Supplementary Methods).
Occupational Study Subjects
Used as additional replication material and in methylation anal-
yses, occupational subjects comprised employees from two 
sectors. The baseline phase of the airline study for prevention 
of type 2 diabetes was collected during the volunteer employee 
health checks of a Finnish airline operating primarily along Asia–
Europe traffic routes.23 Of the 2312 study subjects, those with full 
baseline data and no diabetes (n = 40 with diabetes based on their 
baseline glucose levels) were invited to the follow-up study 2.5 
years later, and 1347 participated.24 The participants of the fol-
low-up study who had information from MBI-GS and from work 
schedules, gave permission for DNA sampling, and had success-
ful genotyping, numbered 821. The shift-working subjects were 
defined by the questions “How many night shifts do you have 
per month (at least 3 hours between 23.00–06.00)?” and “How 
often in your shift work schedule you have following working 
times: Early morning shifts starting before 6 am?” The answers 
were further verified from the working schedule system. As shift 
workers, we classified subjects with night shifts ≥3/mo, and/or 
early morning shifts ≥1/wk. Of the included study subjects, 606 
were classified as shift workers and comprised our airline study, 
which included in-flight workers (n = 263), who served as pilots 
or flight attendants, and non-flight workers (n = 343), who held 
various occupations at the airport. The non-flight workers consti-
tuted a separate group, analyzed post hoc, because they had much 
higher exhaustion scores compared to the other occupational and 
population-based groups (Table 1). In addition to shift-work-
ing non-flight workers, non-flight workers who did not perform 
shift work (n = 193 with successful genotyping and answered to 
MBI-GS) were included in the interaction testing of shift work.
The second occupational group included nurses from the 
Finnish Public Sector Study (n = 73 with successful genotyping 
and answered to MBI-GS)25 (Table 1). All the nurses had a shift 
work schedule with three different shifts: morning, evening, 
and night.
For all the contributing studies, the local institutional review 
boards on human research approved the study protocols, and 
the participants gave their informed consent.
Measure for Job-Related Exhaustion
Job-related exhaustion was assessed in all studied data sets 
using the emotional exhaustion subscale from the MBI-GS.26,27 
The MBI-GS questionnaire is suitable for any profession, and 
its reliability and validity have been confirmed.28,29 The emo-
tional exhaustion subscale comprises five symptom statements 
with a frequency scale ranging from 0 (never) to 6 (daily). One 
missing value was allowed. After logarithmic transformation 
to achieve a normal distribution, the sum score for emotional 
exhaustion was treated as a quantitative trait.
Genotyping and Quality Control
Genome-wide genotyping in the Health 2000 GWAS study was 
performed using Illumina’s Human610-Quad DNA Analysis 
BeadChip (Illumina, Inc., San Diego, CA). Markers with MAF 
<1% or Hardy–Weinberg equilibrium (HWE) p < 1 × 10−6 were 
excluded from the analyses. For individuals and markers, the 
call rate was >95%. Data selection and genotyping in GenMets 
have been described previously in detail.27
Genotyping of the Health 2000 replication study and of 
the occupational studies (HWE p > 1 × 10−6) was performed 
by MassARRAY genotyping using iPLEX Gold chemistry 
(Sequenom, San Diego, CA). In the Health 2000 replication 
study of 270 shift workers who answered the MBI-GS, the gen-
otyping success rate was 97.4% for rs12506228 and 96.6% for 
rs3821986. Call rate for individuals was 95% and altogether 
28/270 subjects were excluded. The success rates for genotyp-
ing of rs12506228 were 100% in the nurse study and 99.9% in 
the in the airline study. The call rate for individuals was 95% in 
the airline study, and two subjects from the non-flight workers 
of the airline were removed.
Capillary sequencing was employed to sequence of the hap-
lotype region of rs12506228, whilst fragment analysis was 
used to further investigate the related microsatellite marker 
(Supplementary Methods and Table S9).
Association Analyses
For genetic association analyses we utilized linear regression 
analysis of PLINK, version 1.07,30 with an additive model and 
covariates of age and sex. In the GWAS, case-control status for 
metabolic syndrome and 20 EIGENSTRAT principal compo-
nents were used as covariates to control for enrichment of the 
cases of metabolic syndrome in the Health 2000 GWAS study 
and potential population stratification, respectively. PLINK 
was also used for the haplotype analyses (Supplementary 
Methods) and interaction testing, which was calculated using 
PLINK’s interaction command which adds the interaction 
term on the linear regression model. Beta and p values for 
the interaction term were reported in the model including 
covariates of age and sex. The main effect of the shift work 
environment on job-related exhaustion was calculated with a 
linear regression model in SPSS (IBM, SPSS statistics, ver-
sion 23), as this was unavailable in PLINK. Haplotype struc-
ture was determined with the confidence interval method of 
the Haploview software, version 4.2 (Haploview, version 4.2, 
Daly lab at the Broad Institute, MA).31 In the meta-analysis, 
we assumed a similar true genetic risk effect in all the study 
groups which all included shift workers with a Finnish back-
ground, and Health 2000 GWAS and Health 2000 replication 
studies were part of the same sampling procedure. All the 
studies included in the meta-analysis (the Health 2000 studies, 
in-flight workers of airline study, and the nurse study) also had 
female prominence, mean ages, and exhaustion scores close 
to each other (Table 1). Meta-analyses were performed using 
the fixed-effect model in GWAMA.32 Heterogeneity between 
studies was tested with GWAMA using measures of Cochran’s 
Q-test and I2 index. In the case of heterogeneity, the source of 
heterogeneity was searched and analysis excluding those stud-
ies was also performed. The random-effect model was omitted 
due to the low number of studies in the meta-analysis (2–4), 
which renders it unreliable.33
In the GWAS, correction for multiple testing was handled by 
considering the level of significance as p < 5 × 10−8, which is the 
classical threshold used in GWAS studies. In other instances, 
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Bonferroni corrections were performed with the formula p
Bonfer-
roni
 = 1−(1−p)k, where p is the uncorrected p value and k number 
of tests.
Gene Expression in eGWAS Mayo Data
To examine association of rs12506228 with melatonin recep-
tor 1A gene (MTNR1A) expression, we used publicly avail-
able eGWAS Mayo data through the National Institute of 
Aging Genetics Data Storage Site (NIAGADS).34 The data set 
included gene expression profiles of cerebellum and tempo-
ral cortex, and genome-wide single nucleotide polymorphism 
(SNP) genotyping data for patients with neuropathologically 
verified Alzheimer’s disease (AD) pathology and non-AD 
individuals, many of whom had other brain pathologies (55% 
with progressive supranuclear palsy, 13% with Lewy body 
disease, 12% with corticobasal degeneration).To avoid the 
effect of widespread neurodegeneration related to AD, only the 
non-AD subjects (n = 177, cerebellum) were included in this 
study. Gene expression levels were measured with the Whole 
Genome DASL assay (Illumina, Inc., San Diego, CA). Probes 
with detection in less than 75% of the samples were excluded. 
A probe for MTNR1A was excluded in the temporal lobe sam-
ples and therefore only results for cerebellum were reported. 
The SNP genotyping was based on Illumina’s HumanHap300-
Duo Genotyping BeadChips. Available statistics from the 
eGWAS Mayo data were based on linear regression analysis of 
PLINK using an additive model and covariates of age at death, 
gender, PCR plate, and RNA integrity number (RINmean).2
DNA Methylation Analyses
For the methylation study, to minimize variation in methyla-
tion levels due other reasons, subjects were excluded from all 
groups due to several circumstances, including: smokers; those 
using hormonal medication or medication affecting cognitive 
functions; and alcohol users exceeding the risk-use guidelines 
in Finland. The analyses of DNA methylation included 20 pilots 
(all males), 20 flight attendants (all females) from the airline 
study, as well as 20 nurses from the Finnish Public Sector Study 
(all females). In pilots and flight attendants, both individuals 
engaged and not regularly engaged in flights that cross time-
zones (a minimum of four time-zones for over 3 years prior 
to measurement) were included (10 + 10 in both occupational 
groups). Individuals in the nurse study35 had worked for at least 
3 years in the same ward either collectively evaluated to be a 
high-stress (n = 10) or low-stress (n = 10) environment.35 The 
groups were matched pairwise for age as well as possible with 
the limited number of subjects.
DNA methylation was assessed using Illumina Infinium 
HumanMethylation 450k BeadChips (Illumina, Inc., San Diego, 
CA). First, 500 ng of genomic DNA was treated with sodium 
bisulfite using the EZ96 DNA Methylation Kit protocol (Zymo 
Research). DNA methylation was assessed using Illumina 
Infinium HumanMethylation 450k BeadChips (Illumina, Inc.). 
A duplicate sample was included in each chip to control for 
the batch effect and methylation controls were included for 0% 
and 100% methylation (Epitech). DNA samples were processed 
according to the manufacturer’s protocol. Preprocessing, correc-
tion, and normalization steps were implemented in the R-studio 
environment (version 0.97.318) using the Bioconductor software 
packages (version 2.12). Methylation data was extracted as raw 
signals (IDAT files) and loaded into the R environment using the 
minfi software package (version 1.18.2).36 A subset quantile nor-
malization approach (SWAN37) was used to adjust the intensities 
in each array and to correct for technical differences between 
type-I and type-II assays. At this stage, probes with a detec-
tion of p > .01 for any DNA sample or missing measurements, 
known cross-reactive probes, probes on X and Y chromosomes, 
and probes that contain either a SNP at the CpG interrogation 
or at the single nucleotide extension were excluded from sub-
sequent analysis. All methylation values were converted to M 
values (log2 ratio of the measured intensities of the methylated 
probe vs. the unmethylated probe) in order to provide a more 
accurate interpretation of the methylation levels at the extreme 
ends (high and low methylation) compared to the beta values.38 
The lymphocute cell counts (CD8T, CD4T, natural killer cells, B 
cells, monocytes, and granulocytes) were derived from the meth-
ylation data as implemented in the minfi package.
The association of the SNP with the CpG sites was calculated 
separately for each occupational group using a linear regression 
analysis with an additive model in SPSS (IBM, SPSS Statistics, 
version 23) to avoid a variance due to group, and then com-
bined using the fixed-effect model in GWAMA. Lymphocyte 
cell counts for the six cell lines and methylation chip (slide) 
were added on the regression model as covariates. One individ-
ual from the nurses was excluded due to incomplete bisulfite 
conversion, and one individual from the pilot group due to 
outlying methylation value for cg04188238 (>3.0 SD from the 
mean M-value). Age was a non-significant covariate, and it was 
not included in the model.
RESULTS
GWAS and the First Replication Analysis Revealed an  
Association of a Variant Close to MTNR1A With Job-Related 
Exhaustion Among Shift Workers
To identify genetic risk variants for intolerance to shift work, 
we first performed a GWAS for job-related exhaustion among 
shift workers in the Health 2000 GWAS study (n = 176) 
(Figure 1, Supplementary Figure S1, Supplementary Table 
S2). No genome-wide significant associations (p < 5 × 10E-8) 
emerged, but the two SNPs with the strongest association with 
the trait (suggestive association, p < 5.0 × 10−6), rs3821986 and 
rs12506228, were selected for genotyping in the Health 2000 
replication study (n = 241). This replication study revealed 
no association of rs3821986 with job-related exhaustion, but 
an association with rs12506228 was replicated (β = 0.23, 
p
Bonferroni
 = .048) (Figure 1). rs12506228 is located 70 kb down-
stream from the gene encoding for the melatonin receptor type 
1A (MTNR1A).
To determine whether the effect of the risk variant rs12506228 
on job-related exhaustion was specific to shift workers, all 
workers from Health 2000 (417 shift workers and 2484 non-
shift workers) were analyzed for gene-environment interactions. 
Among shift workers the association with job-related exhaus-
tion was detected (Supplementary Table S10), and we saw a 
significant interaction effect with rs12506228 and shift-work 
status (β = 0.33, p = 6.1 x 10−5). No association with job-related 
exhaustion was seen among non-shift workers (β = 0.0024, p = 
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.94). Shift work environment in itself presented no significant 
main effect on job-related exhaustion (β = 0.010, p = .84). Thus, 
in the Finnish population-based GWAS and replication studies, 
we were able to show a suggestive association of rs12506228, a 
variant close to MTNR1A, with job-related exhaustion, specifi-
cally in shift workers.
Association With MTNR1A Variant was Replicated  
in an Occupational Cohort
We next attempted to find further evidence for the association 
of rs12506228 with job-related exhaustion in shift workers by 
replicating the analysis in two occupational groups with shift-
work schedules, in-flight workers of a Finnish airline (n = 263) 
and three-shift-working nurses (n = 73), using the same measure 
as the population-based studies—MBI-GS. We found a signif-
icant replication in the in-flight workers (β = 0.21, p = .0076). 
The smaller nurse study, while not significant, showed a similar 
effect size and direction (β = 0.23, p = .21). There was an insuf-
ficient number of in-flight workers and nurses who lacked shift 
work, rendering the calculation of interaction with shift work 
impossible.
Shift-working non-flight workers from the same Finnish air-
line (n = 343) differed greatly compared to other groups in their 
level of job-related exhaustion (t test, p = 8.91 × 10−9 compared 
to the in-flight workers; Levene’s test of equality, p < .05), and 
gender distribution (Table 1). Post hoc analysis in this group 
showed a nonsignificant trend of association of rs12506228 
with job-related exhaustion, but an opposite direction of effect, 
and a weaker size of effect, in comparison to other groups 
(β = −0.15, p = .08). There was also no interaction with shift 
work (n = 343 + 193, β = −0.21, p = .13), and no association 
with job-related exhaustion among non-shift-working non-
flight workers (β = 0.073, p = .51).
Meta-analysis Showed Association With the MTNR1A  
Variant and Heterogeneity Between Studies
Combining the results from the population-based Health 
2000 cohort, the in-flight airline workers and the nurses, the 
fixed-effect meta-analysis for the association of rs12506228 
with job-related exhaustion in shift workers reached genome-
wide significance (β = 0.29, p = 4.90 × 10−8) (Figure 2). The 
meta-analysis showed, however, moderate inter-study heteroge-
neity (i2 = 0.64, Q statistics p = .040). The source of heteroge-
neity was the Health 2000 GWAS study, which showed a bigger 
effect size compared to other studies (Figure 2). The three rep-
lication studies showed no heterogeneity (i2 = 0, Q statistics p 
=.97) and their fixed-effect meta-analysis showed significant 
replication signal (n = 577, β = 0.22, p = 1.95 × 10E-4). Thus, 
the original association of rs12506228 with job-related exhaus-
tion in shift workers was replicated highlighting a genetic 
region near MTNR1A, a receptor for melatonin.
Fine Mapping of the rs12506228 Genomic Region Revealed 
Linked SNPs and a Novel Microsatellite Marker
To investigate if the marker rs12506228 was in linkage disequi-
librium (LD) with other, potentially causative variants, we car-
ried out a haplotype analysis of rs12506228 and the surrounding 
region, and examined the haplotype area by capillary sequenc-
ing. By performing the haplotype analysis, we were able to 
narrow down the genomic region of interest to an 11-kb area 
centromeric to MTNR1A (Figure 3, Supplementary Results, 
Supplementary Figure S2, Supplementary Table S3). The 
Figure 2—Meta-analysis for the association of  rs12506228 with 
job-related exhaustion in shift workers. The Forrest plot presents 
the effect sizes (β) and standard errors (SE) for the linear regres-
sion analysis of  each study.
Figure  1—Genome-wide association study (GWAS) for job-re-
lated exhaustion in shift workers and the first replication study. 
A quantile–quantile plot was calculated for expected and observed 
test statistics for the GWAS in the Health 2000 GWAS study 
(n = 176). Replication analyses were performed in the Health 2000 
replication study (n = 241) for the highest ranking two variants (ta-
ble embedded). CHR:MB, chromosome:locus in megapairs.
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sequencing of that region (bp 187 375 836–187 388 519) led to 
the identification of three variants which segregated fully with 
rs12506228: two SNPs (rs7684546 and rs78783920) and an 
intermediate-length allele (named here 13m) of a novel micro-
satellite marker with an unknown function (Supplementary 
Table S4). In addition, in the Genmets Illumina chip data 
rs12506228 showed strong LD (R2 = 0.936) with one of the 
haplotype markers, rs11723770, but in the sequencing that 
variant was at the unsuccessfully genotyped self-chain region. 
The microsatellite was further characterized with fragment ana-
lysis in Vantaa 85+ and Kuopio 75+ which revealed 10 differ-
ent repeat polymorphisms (Figure 3, Supplementary Table S5). 
Since the SNPs and the 13m allele of the microsatellite were 
virtually in complete LD with the tagging variant rs12506228, 
their effect could not be distinguished from that of rs12506228 
with our study size (Supplementary Results).
rs12506228 was Associated With MTNR1A Gene  
Expression Levels
To explore if the association of rs12506228 with job-related 
exhaustion in shift workers is mediated through changes 
in gene expression, we performed an in silico search of the 
publicly available eGWAS Mayo data34 for allele-specific 
expression differences in MTNR1A in the post-mortem human 
cerebellum (n = 176). The MTNR1A expression levels in the 
carriers of the risk allele A of rs12506228 were significantly 
reduced (β = −0.26, p = .0046). The association of rs12506228 
with MTNR1A was the most significant of the 38 available 
SNPs that were situated less than 100 kb from MTNR1A. These 
findings suggest that the reduced MTNR1A expression linked 
to the risk allele is a mediating mechanism for the association 
of rs12506228 with job-related exhaustion in shift workers.
rs12506228 Linked to Methylation at the 5' Regulatory  
Region of MTNR1A
The interaction of rs125056228 with the shift work environ-
ment and the association of that variant with gene expression 
led us to search for epigenetic changes as a mediating mecha-
nism for the detected associations. We explored the association 
of rs12506228 with methylation of the CpG sites available in the 
Illumina HumanMethylation450K BeadChip in the 5' regulatory 
region of MTNR1A (n = 16). In the meta- analysis of pilots, flight 
attendants, and nurses (n = 59), three of these CpG sites presented 
nominally significant association (p < .05) so that cg04188238 and 
cg12896146 showed higher methylation levels in association with 
the A allele of rs12506228 (cg04188238 β = 0.148, p = .0075, 
p
Bonferroni
 = .114; cg12896146 β = 0.15,p = .019, p
Bonferroni
 = .264) 
and cg10063179 lower methylation levels (β = −0.141, p = .0048, 
p
Bonferroni
 = .074) (Figure 4, Supplementary Table S6). Thus, 3/16 
CpG sites at the regulatory region of MTNR1A showed nominally 
significant associations of p < .05 with rs12506228, but these did 
not remain significant after Bonferroni correction. Many of the 16 
sites are highly intercorrelated, however, thus do not represent inde-
pendent tests, (eg, Spearman’s ρ = 0.632 between cg04188238 and 
cg12896146, Supplementary Table S7), making Bonferroni cor-
rection a conservative approach for correction of multiple testing.
DISCUSSION
We present here a GWAS followed by replication studies to 
explore genetic differences in tolerance to shift work, assessed 
Figure 3—Genetic map of  the MTNR1A area. Rs12506228 was part of  a 7-SNP haplotype (rs6835758-rs1839746-rs7670038-rs2100281-
rs12506228-rs6846710-rs11723770). Capillary sequencing of  that haplotype area in 14 individuals revealed two SNPs and an allele (13m) of  a 
novel microsatellite marker perfectly linked to rs12506228 (marked with red). In the CpG island and shores of  the 5' regulatory region of  MTN-
R1A, three of  the 16 methylation sites (marked with box) showed nominally significant association with rs12506228. LD, Linkage disequilibrium.
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by measuring job-related exhaustion in shift workers. The second 
strongest signal identified in the GWAS, observed at rs12506228, 
showed two independent replications and the meta-analysis for 
replication studies was highly significant (p = 2.0 × 10E-4). Even 
though no candidate genes were selected prior to investigation, 
that SNP finding is situated close to the gene coding for the mel-
atonin receptor type 1A, one of two high-affinity receptors for 
melatonin, a hormone that serves as an indicator of our biologi-
cal night and circadian rhythm. The genetic association analyses 
were complemented with a database search on gene expression 
using the eGWAS Mayo data, which showed decreased brain 
expression of MTNR1A in carriers of the rs12506228 risk allele. 
In addition, rs12506228 showed tendency for association with 
blood DNA methylation in the 5' regulatory region of MTNR1A, 
which suggests that rs12506228 may regulate gene expression 
through differential methylation.
We sought to find differences in job-related exhaustion 
symptoms specifically in shift workers, in order to estimate 
the ability to cope with the circadian challenge that shift work 
presents. The second strongest signal identified in the GWAS, 
rs12506228, showed significant replication in two of the rep-
lication data sets. Among the replication data sets, the general 
population of the Health 2000 replication cohort, in-flight air-
line workers, and nurses, the effect size was similar, and smaller 
to that in the initial GWAS study. This is likely due to the initial 
study’s tendency to overestimate the genetic effect, as reported 
previously.39 Nonetheless, among the individuals in the post-
hoc study comprising non-flight workers of the airline with 
remarkably higher job-related exhaustion scores (Table 1), the 
same variant showed a nonsignificant trend of association with 
an opposite direction of effect. We assume that the effect of 
rs12506228 in most of the occupational groups is close to that 
in the replication studies, β (standardized) ~ 0.2, but not all spe-
cial occupational groups show similar results. The background 
for this heterogeneity, perhaps related to the level and back-
ground of job-related exhaustion symptoms, must be studied 
further. Attempts to replicate this genetic association in differ-
ent populations and occupational groups are encouraged.
In addition to the environment, genomic variants also affect 
DNA methylation.40 The risk allele rs12506228A was sugges-
tively linked to methylation of the CpG sites in the 5' regulatory 
region of MTNR1A. This finding might explain lower expression 
levels of MTNR1A detected in association with rs12506228A, 
since DNA methylation is considered to participate in the con-
trol of gene expression. In our study, however, methylation was 
measured from blood cells, whereas SNP-expression associa-
tions were detected in cerebellar brain tissue. The inter-individ-
ual variation in the DNA methylation patterns of the peripheral 
blood cells is reported to reflect that in the cerebellum of the 
same individual (correlation = 0.76, p < .001, n = 2).41 When 
examining similarities in methylation quantitative loci (meQTL) 
between peripheral blood and five brain areas, significant overlap 
occurred which varied from 6.6% to 35.1% depending on brain 
area. This result was evident despite comparing different types 
of tissue samples from different individuals, and the donors for 
blood or postmortem brain samples also derived from different 
ancestral backgrounds.42 Thus, we suggest that the peripheral 
blood serves as a surrogate for methylation differences in brain, 
and that rs12506228 may regulate MTNR1A expression in brain 
Figure  4—Rs12506228 and methylation levels of  CpG sites 
cg04188238, cg12896146, and cg10063179 in the 5' regulatory 
region of  MTNR1A. Boxplots for the methylation M-values in the 
groups of  nurses (n = 5 (C/C) + 11 (C/A) + 3 (A/A), flight attend-
ants (n = 10 (C/C) + 7 (C/A) + 3 (A/A), and pilots (n = 9–10 (C/C) 
+ 7 (C/A) + 3 (A/A)) for (A) cg04188238, (B) cg12896146, and (C) 
cg10063179.
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via methylation differences. However, the mechanism underlying 
the suggestive association of rs12506228 with methylation in the 
5' region of MTNR1A remains to be clarified, and replication for 
brain specimens assessed for methylation and expression data is 
needed to confirm this hypothesis.
Proposed Mechanisms
Association of the risk allele of rs126506228 and reduced 
MTNR1A expression was visible in cerebellum, but because of 
the similarities in SNP-expression associations in the cerebel-
lum and other brain areas,34 the association may be similar in the 
suprachiasmatic nucleus (SCN). This could lead to reduced mel-
atonin signaling to SCN through type 1A melatonin receptors in 
the carriers of the risk allele. According to previous studies,43–46 
and discussed in47,48, physiological melatonin signaling may sta-
bilize the circadian rhythm against light-induced phase shifts, 
although some controversy remains.49 This effect of melatonin 
is likely conveyed through the inhibitory effect of melatonin 
receptors type 1A in the SCN.48 The relative shortage of mela-
tonin receptors type 1A in the SCN in carriers of the risk allele 
of rs12506228 may, thus, lead to a higher sensitivity to noctur-
nal light. In night shift workers, despite nocturnal light, there is 
melatonin secretion when they are working their shift.50 If the 
stabilizing melatonin signal is, however, reduced due to relative 
lack of type 1A melatonin receptors, it would lead to an increased 
phase-shifting effect of nocturnal light. Because most night shift 
workers51 or rotational shift workers lack time to adjust their bio-
logical rhythms to the activity rhythm of their working shift, they 
are unlikely to benefit from a pronounced phase-shifting effect 
of light but it rather increases circadian disruption,52 which could 
lead to symptoms of intolerance to shift work.9,53
Limitations and Strengths
The biggest limitation for our study is the small study size and 
limited power, especially in the initial GWAS study (power cal-
culations, Supplementary Methods). Given the modest study 
size, our study showed a surprisingly consistent genetic asso-
ciation with significant replications for rs12506228 in two 
separate studies. One reason may have been our relatively 
genetically homogenous group of individuals (only Finnish 
subjects) which was further limited to a specific group of work-
ers, shift workers.54 The phenotype was also defined similarly 
across all studies using the MBI-GS questionnaire, a meas-
ure that was able to reveal a replicable molecular genetic risk 
factor among the whole worker population.27 For example, in 
the search for the genetic background of depression, a phe-
notype that presents substantial etiological heterogeneity, the 
CONVERGE consortium showed that the use of a homoge-
nous subjects, in terms of ethnicity and phenotype, resulted in 
greater success at finding genetic risk variants.55 We attribute 
the appearance of this seemingly true positive finding, based 
on significant replications, to the homogeneity of our subjects. 
Still, false negative findings could exist but cannot be exam-
ined further in this study due to a lack of genome-wide data in 
the replication studies.
The initial GWAS study was originally selected for the 
case-control study of metabolic syndrome, which somewhat 
enriched that group for metabolic syndrome and did not keep 
it representative of Finnish population. However, covari-
ation for the metabolic syndrome status was performed in 
the GWAS, and the first replication study represented the rest 
of the same population-based group from which the initial 
selection for GWAS was made. No significant differences 
were detected in the job-related exhaustion scores or the key 
covariates among cases and controls (Supplementary Table 
S1), and nearly similar sized effects of rs12506228 were 
detected when the cases and controls for metabolic syn-
drome in the initial GWAS study were analyzed separately 
(Supplementary Table S8).
A limitation of our study is the use of only subjective meas-
ures. There is no consensus on good objective measures for 
intolerance to shift work, even though some have measured 
circadian rhythms, for example, with actigraphy or cognitive 
performance tasks administered at different times during the 
shift.9 We assessed job-related exhaustion, which is a subjective 
experience by nature and cannot be measured objectively, but 
with questionnaires like MBI-GS, a commonly used measure for 
burnout validated across occupations.29 Registrations of sleep or 
circadian rhythm at the magnitude needed for molecular genetic 
studies are very resource intensive. Hypotheses created in asso-
ciation studies with subjective measures and more subjects 
may be tested in studies with experimental settings and fewer 
subjects.
CONCLUSIONS
Overall, we show here that genetic risk variants associating 
with the level of job-related exhaustion in shift workers may 
be identified using a GWAS-based approach. One of the most 
significant findings of our GWAS replicated independently 
in two of our replication studies, and we were also able to 
suggest an epigenetic regulatory mechanism for how the risk 
variant could reduce MTNR1A expression. Reduced internal 
melatonin signaling through decreased MTNR1A expression 
may lead to an increased sensitivity of the circadian regula-
tory system to nocturnal light and, therefore, diminish an indi-
vidual’s capacity to cope with changing schedules. To further 
examine the proposed model, experimental settings are nec-
essary. Coping with irregular working hours is an important 
issue for our modern society and we are only beginning to 
shed light on the biological differences which contribute to 
the phenomenon.
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